{"id":214946,"title":"Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T18:51:25.099000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age.html?wbdisable=false","snippet":"Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17] - Canada.ca Skip to main content Skip to \"About government\" We have archived this page and will not be updating it. You can use it for…","rawSnapshotUrl":"/api/snapshots/raw/214946","browseUrl":"https://replay.healtharchive.ca/job-1/20250418185125/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age.html?wbdisable=false#ha_snapshot=214946","mimeType":"text/html","statusCode":200}